Zdrowie i gospodarka · 10/12/2021

FDA Reopens Comment Period for Real-World Data Guidance on Drug and Biological Products

The US Food and Drug Administration (FDA) is extending the comment period for its draft guidance on using real-world data to support regulatory decisions on pharmaceuticals and biologics, allowing more time for public input.